Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-11

Clinical Trial Update: Efgartigimod for Stiff Person Syndrome (ESPS) [Phase 2]

View source ↗

Summary

A Phase 2 trial assessing efgartigimod for stiff-person syndrome is listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Efgartigimod (efgartigimod)

Snippet

Sponsor: University of South Florida | Conditions: Stiff-Person Syndrome | Phase 2 | Status: NOT_YET_RECRUITING